news

HighTide Therapeutics to Present Analyses of Phase 2 MASH Study at AASLD’s The Liver Meeting 2024

HONG KONG, Oct 25, 2024 – (ACN Newswire) – HighTide Therapeutics, Inc. (2511.HK), a clinical stage biopharmaceutical company specializing in the development of multifunctional multi-targeted therapies for chronic liver and metabolic diseases, will present at the American Association for the Study of Liver Diseases’ (AASLD) The Liver Meeting®, taking place from November 15-19, 2024 in San…

Read more

Foodrella Tteokbokki Captivates Global Taste Buds

SEOUL, S.KOREA, Oct 25, 2024 – (ACN Newswire) – Foodrella, a Korean food brand, has launched a product that allows global consumers to create authentic K-food with a simple recipe. Once considered a casual snack, tteokbokki has now become deeply embedded in the culinary cultures of the U.S., Europe, and Asia, positioning itself as a…

Read more